It's Time for the Epstein Story to Be Buried
A New Poll Shows Old Media Resistance, and Nicolle Wallace Decides Which Country...
Is Free Speech Really the Highest Value?
Dan Patrick Was Right — Carrie Prejean Boller Had to Go
The Antisemitism Broken Record
Before Protesting ICE, Learn How Government Works
Republican Congress Looks Like a Democrat Majority on TV News
Immigration Is Shaking Up Political Parties in Britain, Europe and the US
Representing the United States on the World Stage Is a Privilege, Not a...
Older Generations Teach the Lost Art of Romance
Solving the Just About Unsolvable Russo-Ukrainian War
20 Alleged 'Free Money' Gang Members Indicted in Houston on RICO, Murder, and...
'Green New Scam' Over: Trump Eliminates 2009 EPA Rule That Fueled Unpopular EV...
Tim Walz Wants Taxpayers to Give $10M in Forgivable Loans to Riot-Torn Businesses
The SAVE Act Fight Ends When It Lands on Trump's Desk for Signature
OPINION

Stocks in the News: China Arrests 4 in Glaxo Bribery, Prostitution Investigation

The opinions expressed by columnists are their own and do not necessarily represent the views of Townhall.com.
Stocks in the News: China Arrests 4 in Glaxo Bribery, Prostitution Investigation

Stocks in the News is produced by Ransom Notes Radio and Goodfellow, LLC. Crista Huff manages Goodfellow LLC, a website that recommends outperforming stocks using fundamental and technical analysis. 

Advertisement

Stock number one is: 

GlaxoSmithKline PLC, (SYMBOL: GSK) and the headline says:

GlaxoSmithKline executives arrested in China bribery investigation -- World News Views

Four senior Chinese executives have been arrested in a criminal investigation against healthcare company GlaxoSmithKline, after Glaxo allegedly used extensive bribery to increase sales.  Bribes allegedly totalled $489 million, and were spent on fraudulent travel and meeting expenses, and sexual favors, to 700 companies, doctors and officials.

A separate Chinese pricing investigation could potentially cause greater harm to  pharmaceutical companies, as it did with Mead Johnson and other baby formula manufacturers earlier this month.

The stock chart is neutral and the price has not been affected by the potential $5-$10 million dollar fine.

Our Ransom Note trendline says:  HOLD GLAXOSMITHKLINE.

GSK Chart

GSK data by YCharts

Stock number two is: 

Coca-Cola Co., (SYMBOL: KO) and the headline says:

A Perfect Storm -- Bad Weather Nearly Everywhere Depresses 2Q Volume Growth – Citi Research

Coca-Cola reported earnings in-line with expectations today, masking sales problems generated from bad global weather, weak economies, unfavorable foreign exchange rates, and negative PR on sugary soft drinks.  Global sales volume grew 1%, far below the 3.3% average estimate.

Earnings are expected to grow 6-9% per year for the next three years.  The dividend yield is 2.79% and the PE is 19.

Advertisement

The stock has been trading between $39 and $43 for four months, and will likely remain there for the time being.

Our Ransom Note trendline says: HOLD COCA-COLA.

KO Chart

KO data by YCharts

Stock number three is:

DreamWorks Animation Inc., (SYMBOL:  DWA) and the headline says:

Profits of $0.18 per share anticipated for Dreamworks Animation's second quarter -- Reuters

Wall Street is bullish on DreamWorks Animations’ second quarter report due out on July 31, despite weak peer group performance.  DreamWorks is the maker of the hit movie Shrek, and tomorrow’s new release Turbo.

The company lost $53 million last year, and is expected to earn 83 cents per share this year.  Anaylsts are expecting between five and forty cents per share for the quarter, which means we’ll see volatility when earnings are announced.

The stock is up 33% since we recommended it as a trading buy on March 22.  There’s price support at $24 and $22.  Shareholders should protect recent profits with stop-loss orders.

Our Ransom Note trendline says:  HOLD DREAMWORKS ANIMATION.

DWA Chart

DWA data by YCharts

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement